Evaluating Biosimilar Development Projects: An Analytical Framework Utilizing Net Present Value

The framework demonstrates that early market entry, manufacturing optimization, and market share achievement are key success factors, whereas technical complexity and competitive intensity significantly influence risk-adjusted returns.

Authors

Institutions

Publication Details

Journal
Biologics
Published
2025-03-01
DOI
https://doi.org/10.2147/btt.s514767
Citations
1
Primary Topic
Biosimilars and Bioanalytical Methods
Type
article
Field-Weighted Citation Impact
0.80
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Evaluating Biosimilar Development Projects: An Analytical Framework Utilizing Net Present Value

Ranjit Ranbhor, Priyanka Kulkarni
1 citations
Biologics
Biosimilars and Bioanalytical Methods
0.80
article

Evaluating Biosimilar Development Projects: An Analytical Framework Utilizing Net Present Value

Ranjit Ranbhor, Priyanka Kulkarni
article en
1 citations

Abstract

The framework demonstrates that early market entry, manufacturing optimization, and market share achievement are key success factors, whereas technical complexity and competitive intensity significantly influence risk-adjusted returns.

BiologicsVol. Volume 19
Montclair State University (US), Li Creative Technologies (United States) (US)
Industry, innovation and infrastructure
Openalex Percentile: Top 30%
Biosimilars and Bioanalytical Methods
0.80
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.